₨ NPR
Pangard DR
Pangard DR Tablet, manufactured by Universal Formulation, contains Pantoprazole Sodium Sesquihydrate 40 mg. This medication is a proton pump inhibitor (PPI) used to reduce the amount of acid produced in your stomach.
Key Information about Pangard DR Tablet
Uses
Pangard DR Tablet is prescribed for various conditions related to excess stomach acid, including:
- Peptic ulcer disease
- H. pylori infection
- Gastro-oesophageal reflux disease (GERD)
- Zollinger-Ellison syndrome
- Oesophagitis
- Acid-related dyspepsia
- NSAID-associated ulceration
- Ulcers resistant to H2 receptor antagonists
- Gastrointestinal (GI) bleeding from stress
Description
Pangard DR Tablet is not recommended if you are:
- Concomitantly using rilpivirine, atazanavir, or nelfinavir.
- Lactating.
Precautions
- Gastric malignancy should be ruled out before starting treatment.
- Consider zinc supplementation during IV therapy if you are prone to zinc deficiency.
- Pregnancy: Use with caution.
- Monitoring: Magnesium levels should be monitored before initiation and periodically during prolonged use.
- Lactation: It’s not known if pantoprazole is distributed into breast milk; therefore, it’s not recommended during lactation.
Interactions
Pangard DR may interact with other medications, potentially leading to:
- Increased risk of digoxin-induced cardiotoxic effects.
- Increased risk of hypomagnesaemia with diuretics.
- May increase INR and prothrombin time of warfarin.
- May increase serum concentration of methotrexate and saquinavir.
- Delayed absorption and decreased bioavailability with sucralfate.
- Decreased absorption of ketoconazole and itraconazole.
- Potentially Fatal: May decrease serum levels and pharmacological effects of rilpivirine, atazanavir, and nelfinavir.
Additional information
| form | PACK |
|---|
Reviews
There are no reviews yet.